A clinical assessment of wilson disease in patients with concurrent liver disease

Journal of Clinical Gastroenterology

Volumn 45, Issue 3, 2011, Pages 267-273

  Wong, Robert J ^a   Gish, Robert ^a   Schilsky, Michael ^b   Frenette, Catherine ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b YALE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

genetic mutation analysis; hepatic copper concentration; Kayser Fleischer rings; Leipzig criteria

Indexed keywords

ALKALINE PHOSPHATASE; CERULOPLASMIN; COPPER; PENICILLAMINE; TRIENTINE; ZINC;

ADULT; AGE DISTRIBUTION; ALGORITHM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE LIVER DISEASE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; FEMALE; GENETIC ANALYSIS; HEART ARREST; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; INSOMNIA; LEIPZIG CRITERIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER LEVEL; LIVER TRANSPLANTATION; MALE; MEDICAL ERROR; MEMORY DISORDER; MORTALITY; MULTIPLE ORGAN FAILURE; MUTATIONAL ANALYSIS; NEUROPSYCHIATRY; OVERALL SURVIVAL; PARANOIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPTIC SHOCK; TERTIARY HEALTH CARE; TREMOR; WILSON DISEASE;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; COHORT STUDIES; COPPER; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79951811484     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181dffaa5     Document Type: Article

References (24)

1. Roberts EA, Schilsky MI. Diagnosis and treatment of Wilson's disease: an update. Hepatology. 2008;47:2089-2111. (Pubitemid 351945575)
2. Dobyns WB, Goldstein NP, Gordon H. Clinical spectrum of Wilson's disease. Mayo Clin Proc. 1979;54:35-42.
3. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 1990;12:1234-1239.
4. Nazer H, Ede RJ, Mowat AP, et al. Wilson's disease: clinical presentation and use of prognostic index. Gut. 1988;27:1377-1381.
5. Berman DH, Leventhal RI, Gavaler JS, et al. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 1991;100:1129-1134.
6. Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113:212-218. (Pubitemid 27281776)
7. Ferenci P, Steindl-Munda P, Vogel W, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson's disease. Clin Gastroenterol Hepatol. 2005;3:811-818. (Pubitemid 41116735)
8. Yuzbasiyan-Gurkan V, Johnson V, Brewer GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med. 1991;118:458-465.
9. Scott J, Gollan JL, Samourian S, et al. Wilson's disease presenting as chronic active hepatitis. Gastroenterology. 1978;74:645-651. (Pubitemid 8333129)
10. Milkiewicz P, Saksena S, Hubscher SG, et al. Wilson's disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol. 2000;15:570-574. (Pubitemid 30327064)
11. Sallie R, Chiyende J, Tan KC, et al. Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E. Gut. 1994;35:849-853. (Pubitemid 24193237)
12. Jones RJ, Lewis SJ, Smith JM, et al. Undetectable serum ceruloplasmin in a woman with chronic hepatitis C infection. J Hepatol. 2000;32:703-704. (Pubitemid 30180392)
13. Song YM, Chen MD. A single determination of liver copper concentration may misdiagnose Wilson's disease. Clin Biochem. 2000;33:589-590.
14. McDonald JA, Snitch P, Painter D, et al. Striking variability of hepatic copper levels in fulminant hepatic failure. J Gastrolenterol Hepatol. 1992;7:396-398.
15. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23: 139-142. (Pubitemid 37265785)
16. Silva IS. Cancer Epidemiology: Principles and Methods. Geneva, Switzerland: World Health Organization; 1999.
17. Glow PJ, Smallwood RA, Angus PW, et al. Diagnosis of Wilson's disease: an experience over three decades. Gut. 2000; 46:415-419. (Pubitemid 30313397)
18. Medici V, Trevisan CP, D'Inca R, et al. Diagnosis and management of Wilson's disease: results of a single center experience. J Clin Gastroenterol. 2006;40:936-941. (Pubitemid 44690770)
19. Merle U, Schaefer M, Ferenci P, et al. Clinical diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut. 2007;56:115-120. (Pubitemid 46044897)
20. Cauza E, Maier-Dobersberger T, Polli C, et al. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol. 1997;27:358-362. (Pubitemid 27366217)
21. Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion. 1981;21:169-178. (Pubitemid 11183911)
22. Lech T, Hydzik P, Kosowski B. Significance of copper determination in late onset of Wilson's disease. Clin Toxicol. 2007;45:688-694. (Pubitemid 47394411)
23. Kowdley KV, Knox TA, Kaplan MM. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis. Dig Dis Sci. 1994;39:2416-2420. (Pubitemid 24350024)
24. Frydman M. Genetic aspects of Wilson's disease. J Gastroenterol Hepatol. 1990;5:483-490.